FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099530 [Registered on: 19/12/2025] Trial Registered Prospectively
Last Modified On: 17/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Study on Common Germs and Antibiotic Effectiveness in Urinary Tract Infections (UTIs) in Northwest India 
Scientific Title of Study   Antibiotic susceptibility pattern and bacteriological profiling of uropathogens causing urinary tract infection in a tertiary care hospital of Northwestern India: A cross-sectional study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashu Garg 
Designation  Junior Resident 
Affiliation  Government Medical College, Patiala 
Address  Junior Resident, Room no. 11, Department of Pharmacology, Government Medical College, Patiala (147001), Punjab, India

Patiala
PUNJAB
147001
India 
Phone  9888307650  
Fax    
Email  gargashu512@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jasbir Singh 
Designation  Professor and Head 
Affiliation  Government Medical College, Patiala 
Address  Professor and Head, Room No. 1, Department of Pharmacology, Government Medical College, Patiala (147001), Punjab, India

Patiala
PUNJAB
147001
India 
Phone  9417212020  
Fax    
Email  jsjasbir9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashu Garg 
Designation  Junior Resident 
Affiliation  Government Medical College, Patiala 
Address  Junior Resident, Room no. 11, Department of Pharmacology, Government Medical College, Patiala (147001), Punjab, India

Patiala
PUNJAB
147001
India 
Phone  9888307650  
Fax    
Email  gargashu512@gmail.com  
 
Source of Monetary or Material Support  
Department of Microbiology, Government Medical College, Patiala (147001), Punjab, India 
 
Primary Sponsor  
Name  Government Medical College Patiala 
Address  Government Medical College, Patiala (147001), Punjab, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashu Garg  Government Medical College, Patiala  Room No. 138, Bacteriology Lab, Department of Microbiology
Patiala
PUNJAB 
09888307650

gargashu512@gmail.com 
Dr Ashu Garg  Government Medical College, Patiala  Junior Resident, Room No. 11, Department of Pharmacology
Patiala
PUNJAB 
09888307650

gargashu512@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, GMC, Patiala  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N390||Urinary tract infection, site notspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  99.99 Year(s)
Gender  Both 
Details  1. Urinary samples with significant bacteriuria.
2. Urine culture reports positive for bacterial uropathogens regardless of age, gender, ethnicity, or nationality.
 
 
ExclusionCriteria 
Details  1. Urine culture reports positive for polymicrobial infections involving more than two bacterial species.
2. Urine culture reports positive for uropathogens of non-bacterial aetiology, either as the sole pathogen or in combination with bacteria.
3. Urinary samples with bacteriuria less than 105 CFU/ml.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To estimate the prevalence of different types of bacteria causing urinary tract infection.  2-4 Days 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the current antibiotic susceptibility patterns of bacterial isolates causing urinary tract infection.  2-4 Days 
 
Target Sample Size   Total Sample Size="340"
Sample Size from India="340" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/01/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

ABSTRACT

Introduction: Urinary tract infecĀ­tion (UTI) is known as bacterial growth in the typically sterile urinary tract (kidney and/or bladder). UTIs are among the most common bacterial infections encountered in clinical practice, with their causative agents and antimicrobial susceptibility patterns varying by region and over time.

Aim: To study the prevalence and current antibiotic susceptibility patterns of different types of bacteria causing urinary tract infection.

Materials and Methods: An observational, cross-sectional study will be conducted at Government Medical College and Hospital, Patiala, Punjab. Randomized data of 340 urine culture and antimicrobial sensitivity reports will be taken from the Department of Microbiology. The observations will be recorded as per the Performa attached and will be subjected to statistical analysis, and compare with the data already available in accessible literature.

Clinical Significance: The findings from this study will provide updated insights into the regional epidemiology of uropathogens and their resistance profiles, aiding in the formulation of effective empirical treatment strategies and antibiotic policies. 
Close